← back to search

Behnaz Eshaghi

Massachusetts Institute of Technology · US
Area of research
Molecular Biology · Pharmaceutical Science
Research interest
Research interests include RNA Interference and Gene Delivery, Lipid Membrane Structure and Behavior, Advancements in Transdermal Drug Delivery, and Adsorption and biosorption for pollutant removal.
h-index
10
citations
455
works
14
NIH funding
primary concept
email

Recent publications

On-patient medical record and mRNA therapeutics using intradermal microneedles
Nature Materials 2025cited by 32position: middledoi
Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines
Cell 2025cited by 12position: middledoi
Ferrous nutritional metal-organic framework as food fortificant
Matter 2025cited by 8position: middledoi
CRISPR–Cas9 delivery strategies for the modulation of immune and non-immune cells
Nature Reviews Materials 2024cited by 44position: middledoi
A Machine Learning-Optimized System for Pulsatile, Photo- and Chemotherapeutic Treatment Using Near-Infrared Responsive MoS<sub>2</sub>-Based Microparticles in a Breast Cancer Model
ACS Nano 2024cited by 14position: middledoi
A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines
Nature Biotechnology 2023cited by 170position: middledoi
The role of engineered materials in mucosal vaccination strategies
Nature Reviews Materials 2023cited by 40position: firstdoi
Virus-Mimicking Polymer Nanoparticles Targeting CD169<sup>+</sup> Macrophages as Long-Acting Nanocarriers for Combination Antiretrovirals
ACS Applied Materials & Interfaces 2022cited by 31position: firstdoi
Stiffness of HIV‐1 Mimicking Polymer Nanoparticles Modulates Ganglioside‐Mediated Cellular Uptake and Trafficking
Advanced Science 2020cited by 45position: firstdoi
Membrane-wrapped nanoparticles probe divergent roles of GM3 and phosphatidylserine in lipid-mediated viral entry pathways
Proceedings of the National Academy of Sciences 2018cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ana Jaklenec · Massachusetts Institute of Technology5 papers (2023–2025)Róbert Langer · Laboratoire d’immunologie intégrative du cancer4 papers (2023–2025)Björn M. Reinhard · Boston University3 papers (2018–2022)Suryaram Gummuluru · Boston University3 papers (2018–2022)Maria Kanelli · Massachusetts Institute of Technology3 papers (2023–2024)Hisashi Akiyama · Boston University2 papers (2018–2020)Linzixuan Zhang · Massachusetts Institute of Technology2 papers (2024–2025)Shahad K. Alsaiari · Massachusetts Institute of Technology2 papers (2024–2024)Jooli Han · Massachusetts Institute of Technology2 papers (2023–2024)Dan H. Barouch · Harvard University1 papers (2025–2025)Thomas J. Scriba · South African Tuberculosis Vaccine Initiative1 papers (2025–2025)Bailey Ingalls · Massachusetts Institute of Technology1 papers (2023–2023)John E. Straub · Boston University1 papers (2018–2018)Ilin Sadeghi · Massachusetts Institute of Technology1 papers (2023–2023)Apurva Pardeshi · Massachusetts Institute of Technology1 papers (2024–2024) · 1 papers (2023–2023)Fangzheng Chen · Sun Yat-sen University1 papers (2025–2025)Shoko Wakabayashi · University of Massachusetts Chan Medical School1 papers (2025–2025)Erika Yan Wang · University of Toronto1 papers (2025–2025)Gary Li · Massachusetts Institute of Technology1 papers (2023–2023)